Pregnancy outcomes in women with inflammatory bowel disease: A 10-year nationwide population-based cohort study

被引:52
作者
Lee, Han H. [1 ,2 ]
Bae, Jung M. [3 ]
Lee, Bo-In [1 ,2 ]
Lee, Kang-Moon [1 ]
Wie, Jeong H. [4 ]
Kim, Jin S. [1 ,2 ]
Cho, Young-Seok [1 ,2 ]
Jung, Sung-Ae [5 ]
Kim, Sang W. [1 ]
Choi, Hwang [1 ]
Choi, Myung-Gyu [1 ,2 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterol, Seoul, South Korea
[2] Catholic Photomed Res Inst, Seoul, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul, South Korea
[4] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea
[5] Ewha Womans Univ, Dept Internal Med, Div Gastroenterol, Sch Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
2ND KOREAN GUIDELINES; CROHNS-DISEASE; VOLUNTARY CHILDLESSNESS; HEALTH INSURANCE; BIRTH OUTCOMES; MANAGEMENT; IMPACT; RISK; FERTILITY; DELIVERY;
D O I
10.1111/apt.15654
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Data relating to the association between inflammatory bowel disease (IBD) and pregnancy outcomes are lacking in Korea. Aims To determine the incidence rates of pregnancy outcomes in women with IBD. Methods A nationwide population study was performed using the Korean National Health Insurance claims database. A total of 2058 women with IBD consisting of ulcerative colitis (UC, n = 1469) and Crohn's disease (CD, n = 589) were pregnant between 2007 and 2016. We compared their incidence of pregnancy outcomes with 20 580 age-matched controls without IBD. We also stratified the patients into those with quiescent to mild and moderate to severe IBD and compared the outcomes between them. Results The pregnancy rate of women with IBD was lower than that of women without (25.7% vs 32.3%, P < 0.001). Caesarean section (46.5% vs 38.8%, odds ratio [OR] 1.43, 95% confidence interval [CI]: 1.17-1.75), and intrauterine growth retardation (IUGR) (3.0% vs 1.0%, OR 2.89, 95% CI: 1.59-5.26) were increased in CD patients than the controls. In regards to disease severity, there were no significant differences in pregnancy outcomes between patients with quiescent to mild IBD and the controls. However, the live birth rate of patients with moderate to severe IBD was lower than that of the controls (65.0% vs 69.9%, OR 0.79, 95%CI: 0.66-0.94). In addition, moderate to severe IBD was significantly associated with spontaneous abortion (14.9% vs 11.9%, OR 1.33, 95% CI: 1.04-1.68), caesarean section (46.4% vs 38.8%, OR 1.41, 95% CI: 1.14-1.74) and IUGR (3.4% vs 1.0%, OR 3.20, 95% CI: 1.75-5.84). Conclusions With the exception of moderate to severe disease, the incidences of adverse pregnancy outcomes in women with IBD are similar to that of the general population.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 38 条
[1]   Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease [J].
Abhyankar, A. ;
Ham, M. ;
Moss, A. C. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (05) :460-466
[2]   Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study [J].
Bae, J. M. ;
Lee, H. H. ;
Lee, B. -I. ;
Lee, K. -M. ;
Eun, S. H. ;
Cho, M. -L. ;
Kim, J. S. ;
Park, J. M. ;
Cho, Y. -S. ;
Lee, I. S. ;
Kim, S. W. ;
Choi, H. ;
Choi, M. -G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) :196-205
[3]   INCREASED RISK OF PRETERM BIRTH FOR WOMEN WITH INFLAMMATORY BOWEL-DISEASE [J].
BAIRD, DD ;
NARENDRANATHAN, M ;
SANDLER, RS .
GASTROENTEROLOGY, 1990, 99 (04) :987-994
[4]   Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006 [J].
Bortoli, A. ;
Pedersen, N. ;
Duricova, D. ;
D'Inca, R. ;
Gionchetti, P. ;
Panelli, M. R. ;
Ardizzone, S. ;
Sanroman, A. L. ;
Gisbert, J. P. ;
Arena, I. ;
Riegler, G. ;
Marrollo, M. ;
Valpiani, D. ;
Corbellini, A. ;
Segato, S. ;
Castiglione, F. ;
Munkholm, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (07) :724-734
[5]   Birth Outcomes in Women with Inflammatory Bowel Disease: Effects of Disease Activity and Drug Exposure [J].
Broms, Gabriella ;
Granath, Fredrik ;
Linder, Marie ;
Stephansson, Olof ;
Elmberg, Maria ;
Kieler, Helle .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (06) :1091-1098
[6]  
Bush M C, 2004, J Matern Fetal Neonatal Med, V15, P237, DOI 10.1080/14767050410001668662
[7]   Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database [J].
Cho, Soo-Kyung ;
Sung, Yoon-Kyoung ;
Choi, Chan-Bum ;
Kwon, Jeong-Mi ;
Lee, Eui-Kyung ;
Bae, Sang-Cheol .
RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) :2985-2992
[8]  
Choi CH, 2017, INTEST RES, V15, P7, DOI 10.5217/ir.2017.15.1.7
[9]   The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies [J].
de Lima-Karagiannis, Alison ;
Zelinkova-Detkova, Zuzana ;
van der Woude, Christien Janneke .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (09) :1305-1312
[10]   Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis [J].
Gonzalez-Suarez, Begona ;
Sengupta, Shreyashee ;
Moss, Alan C. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (45) :8082-8089